HealthDay on MSN2 天
Clinical Guidelines Updated for Evaluation, Management, Treatment of CKDIn a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
MedPage Today on MSN12 天
Updated CKD Guidelines Promote Cystatin C, Risk Equations, and SGLT2 InhibitorsUse of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...
前言慢性肾脏病（CKD）、2型糖尿病（T2DM）以及心血管疾病（CVD）都是威胁人类健康的常见疾病，不同疾病间往往会相互影响、相互促进，给临床带来沉重负担。2023年10月美国心脏协会提出“心血管-肾脏-代谢综合征（cardiovascular-ki ...
Chronic Kidney Disease (CKD) is a widespread and frequently under recognised condition impacting millions around the globe. With an ageing population, the prevalence of CKD is projected to rise ...
In patients with CKD, hyperkalemia significantly increases risk for major adverse cardiovascular events and arrhythmia.
The full guideline included 28 recommendations for which there is the greatest evidence and 141 practice points, which reflect the expert opinion of the group. HealthDay News — In a 2024 ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes (KDIGO) organization, a ...
Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...
Improving Global Outcomes (KDIGO) organization updated its existing clinical practice guideline in 2024 on evaluation and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈